Navigation Links
Lupus Research Institute announces 2009 novel research grants
Date:11/24/2009

The Lupus Research Institute (LRI) today named 12 new grant recipients for 2009. The awards, totaling $3.6 million, recognize innovative work across a broad spectrum of lupus research. All were selected for their creativity, novelty, and potential to drive scientific discovery to ultimately prevent, treat, and cure the complex disease of systemic lupus.

The 2009 grants go to both new and established lupus researchers across the nation and include interdisciplinary and highly promising investigations such as:

  • Testing a new way to monitor lupus nephritis (kidney inflammation) without intrusive and sometimes damaging biopsies via noninvasive MRI scans.

  • Pinpointing novel genes specifically associated with lupus in people of African-American ancestrya population more commonly affected by lupus, and also far more likely to experience severe disease.

  • Taking the unconventional approach that nervous system networks modulate inflammation and can be targeted to limit damage to organs in lupus.

"For a decade, the LRI has dedicated itself to innovation and scientific risk-taking in search of new answers and treatments for lupus," said LRI President Margaret G. Dowd. "Recent advances in the corporate sector certainly have demonstrated the value and importance of bold innovation as the pathway to discovery in lupus."

Many of the 2009 grants are innovative studies in human lupus biology that work directly with human tissue in order to hasten the translation of the science into solid human outcomes, advancing the development of new therapies and filling a notable gap in the scientific field.

The $3.6 million in awards to 12 investigators nationwide brings the LRI's total investment for Novel Research Grants to $30 million to 102 investigators at 55 academic medical centers across 22 states.

"A grant from the LRI is known in immunology as very prestigious," said LRI researcher Christopher A.J. Roman, PhD, at the State University of New York Downstate Medical Center (Brooklyn). "Many are very risky grants. They may be built solely upon an idea, as opposed to considerable experimental evidencewhich is normally needed for an NIH proposal. The scientists on the LRI Board have the vision, the foresight and experience to pick those research projects that will hopefully lead to a better understanding of the disease. And then from that, better treatments."

The 2009 LRI grant recipients are:

  • Steven Bensinger, VMD, PhD
    University of California, Los Angeles
    Linking lupus, cardiovascular disease and lipid metabolism

  • Hongbo Chi, PhD
    St. Jude Children's Research Hospital Memphis, TN
    S1P1 receptor in regulatory T cells and lupus pathogenesis and therapy

  • Anne Davidson, MD
    Feinstein Institute for Medical Research Manhasset, NY
    TNF antagonism in SLE

  • Hui-Chen Hsu, PhD
    University of Alabama at Birmingham
    Deletion of lupus autoreactive cells using an anti-hDR5 antibody

  • Timothy Niewold, MD
    University of Chicago Chicago, IL
    Novel Genes Associated with African-American Lupus

  • Marko Radic, PhD
    University of Tennessee Health Science Center Memphis, TN
    Stimulation of Autoreactive B Cells by Apoptotic Bodies

  • Jeffrey Rathmell, PhD
    Duke University Medical Center Durham, NC
    Estrogen Related Receptor-Alpha and B cell Metabolism in SLE

  • Boris Reizis, PhD
    Columbia University Medical Center New York, NY
    Molecular control of self-DNA recognition in lupus

  • Jane Salmon, MD
    Hospital for Special Surgery New York, NY
    Cholinergic modulation of immune complex-mediated inflammatory responses

  • Daniel Stetson, PhD
    University of Washington Seattle, WA
    Cell-Intrinsic Initiation of Autoimmunity in Lupus and Related Diseases

  • Joshua Thurman, MD
    University of Colorado Denver, CO
    Non-Invasive Assessment of Lupus Nephritis

  • Changchun Xiao, PhD
    Scripps Research Institute La Jolla, CA
    Functional Analysis of MicroRNAs in Systemic Immune Tolerance


'/>"/>

Contact: Liane Stegmaier
lstegmaier@lupusny.org
212-812-9881
Lupus Research Institute
Source:Eurekalert

Related biology news :

1. Study identifies genetic risk factor for rheumatoid arthritis, lupus
2. Lupus Research Institute strategy delivers $30 million in national funding
3. Lupus gene finding prompts call for more DNA samples
4. Profound immune system discovery opens door to halting destruction of lupus
5. New approach for attacking lupus identified
6. UT Southwestern secures $5 million NIH grant for lupus research
7. DNA variations signal lupus risk
8. Genes linked with lupus are revealed, giving hope for new treatments
9. The Alliance for Lupus Research announces 2008 grantees
10. Gene linked to lupus might explain gender difference in disease risk
11. UT Southwestern researchers probe kidney damage, protection in lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
Breaking Biology Technology: